SARS-CoV-2 & RSV by LumiraDx
Manufacturer LumiraDx | Available Worldwide
Is it RSV? Is it COVID-19? Actionable results in minutes. Verify potential infection and help guide infection control measures quickly with a rapid microfluidic assay that provides actionable results in 12 minutes, for patients suspected of RSV and/or COVID-19.
SARS-CoV-2 & RSV
.jpg.ashx?maxwidth=140&maxheight=60&bgcolor=white&mode=pad)
Test benefits
- Microfluidic immunofluorescence assay
- Optimize patient and clinical flow - 1 sample, 2 results, 12 minutes
- Helps guide infection control measures quickly
- Sample Type: nasal swab
- Prepared sample can also be used with LumiraDx SARS-Cov-2 & Flu A/B Test
- Easy to implement at point of care
- Time to result in as quick as 12 minutes
- No refrigeration storage required: room temperature storage (2-30°C)
- Minimal handling steps
- Small and portable Instrument
Product Overview
.jpg.ashx?width=100&height=100&bgcolor=white)
